vs
Paysign, Inc.（PAYS）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是Paysign, Inc.的1.9倍（$43.2M vs $22.8M），万物新生净利率更高（16.9% vs 6.0%，领先10.9%）
Paysign, Inc.是一家专业支付解决方案提供商，主打定制化预付卡项目、端到端支付处理服务及数字发放工具，核心服务领域覆盖医疗保健、企业激励与大众消费市场，主要业务和客户群体分布于北美地区。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
PAYS vs RERE — 直观对比
营收规模更大
RERE
是对方的1.9倍
$22.8M
净利率更高
RERE
高出10.9%
6.0%
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $22.8M | $43.2M |
| 净利润 | $1.4M | $7.3M |
| 毛利率 | 57.7% | — |
| 营业利润率 | 8.1% | — |
| 净利率 | 6.0% | 16.9% |
| 营收同比 | 45.8% | — |
| 净利润同比 | -0.7% | — |
| 每股收益（稀释后） | $0.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PAYSRERE
| Q4 25 | $22.8M | — | ||
| Q3 25 | $21.6M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $18.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $15.3M | — | ||
| Q2 24 | $14.3M | — | ||
| Q1 24 | $13.2M | — |
净利润PAYSRERE
| Q4 25 | $1.4M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | $697.1K | — | ||
| Q1 24 | $309.1K | — |
毛利率PAYSRERE
| Q4 25 | 57.7% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 61.6% | — | ||
| Q1 25 | 62.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 55.5% | — | ||
| Q2 24 | 52.9% | — | ||
| Q1 24 | 52.6% | — |
营业利润率PAYSRERE
| Q4 25 | 8.1% | — | ||
| Q3 25 | 7.3% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 13.4% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | -2.0% | — |
净利率PAYSRERE
| Q4 25 | 6.0% | — | ||
| Q3 25 | 10.3% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 4.9% | — | ||
| Q1 24 | 2.3% | — |
每股收益（稀释后）PAYSRERE
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.04 | — | ||
| Q2 25 | $0.02 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $228.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.5M | $557.1M |
| 总资产 | $276.3M | $722.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
股东权益PAYSRERE
| Q4 25 | $48.5M | — | ||
| Q3 25 | $45.8M | — | ||
| Q2 25 | $42.2M | — | ||
| Q1 25 | $39.3M | — | ||
| Q4 24 | $30.4M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $26.9M | — | ||
| Q1 24 | $25.5M | — |
总资产PAYSRERE
| Q4 25 | $276.3M | — | ||
| Q3 25 | $209.5M | — | ||
| Q2 25 | $193.9M | — | ||
| Q1 25 | $205.1M | — | ||
| Q4 24 | $179.0M | — | ||
| Q3 24 | $167.0M | — | ||
| Q2 24 | $182.3M | — | ||
| Q1 24 | $173.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.1M | — |
| 自由现金流经营现金流 - 资本支出 | $47.5M | — |
| 自由现金流率自由现金流/营收 | 208.7% | — |
| 资本支出强度资本支出/营收 | 2.6% | — |
| 现金转化率经营现金流/净利润 | 35.29× | — |
| 过去12个月自由现金流最近4个季度 | $51.2M | — |
8季度趋势，按日历期对齐
经营现金流PAYSRERE
| Q4 25 | $48.1M | — | ||
| Q3 25 | $6.8M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $-6.0M | — | ||
| Q4 24 | $14.3M | — | ||
| Q3 24 | $-20.2M | — | ||
| Q2 24 | $20.6M | — | ||
| Q1 24 | $8.2M | — |
自由现金流PAYSRERE
| Q4 25 | $47.5M | — | ||
| Q3 25 | $6.3M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $-6.1M | — | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $-20.3M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $8.2M | — |
自由现金流率PAYSRERE
| Q4 25 | 208.7% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | -32.9% | — | ||
| Q4 24 | 91.0% | — | ||
| Q3 24 | -133.0% | — | ||
| Q2 24 | 142.4% | — | ||
| Q1 24 | 62.1% | — |
资本支出强度PAYSRERE
| Q4 25 | 2.6% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.4% | — |
现金转化率PAYSRERE
| Q4 25 | 35.29× | — | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 2.62× | — | ||
| Q1 25 | -2.33× | — | ||
| Q4 24 | 10.43× | — | ||
| Q3 24 | -14.03× | — | ||
| Q2 24 | 29.48× | — | ||
| Q1 24 | 26.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PAYS
| Plasma Industry | $12.6M | 55% |
| Pharma Industry | $9.6M | 42% |
| Other | $558.4K | 2% |
RERE
暂无分部数据
